Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study

Fig. 1

Flow diagram of patient selection. The diagram shows the number of patients enrolled in the study and included in the analysis, as well as the number of patients excluded and the reasons for their exclusion (there may be more than one reason for exclusion). Liver dysfunction is defined as grade 2 or higher in any of AST, ALT, T-Bil, or ALP, as evaluated by CTCAE version 5.0

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us